Osteonecrosis of the Jaw among Patients Receiving Antiresorptive Medication

A 4-year Retrospective Study at a Tertiary Cancer Center, Kerala, India

From:
Department for International Development
Published
4 March 2018
Country:
India
Document Type:
Journal Article
Theme:
Health
Authors:
Sankar, P, Thilak, S, Nayak, P and Tripathy, J

Abstrract

Osteonecrosis of the jaw (ONJ) is a rare but complicated side effect of antiresorptive medications. The aim of the study is to evaluate the dental and drug-related factors related to ONJ among patients on these drugs at a tertiary cancer center, India. A retrospective record review of patients who received antiresorptive medication at our center from 2011 to 2014 was done.

This research was supported by the UK Department for International Development’s Operational Research Capacity Building Programme led by the International Union Against TB and Lung Disease (The Union)

Citation

Sankar P, Thilak S, Nayak P, Tripathy J, Satheesan B, Ranjitha A. Oral Health-Related Quality of Life Following Third Molar Surgery in an African Population. Contemporary Clinical Dentistry. 2018;9(1):35–40.

Osteonecrosis of the Jaw among Patients Receiving Antiresorptive Medication: A 4-year Retrospective Study at a Tertiary Cancer Center, Kerala, India

Updates to this page

Published 4 March 2018
Contents